ARSENILATE SOLUTION DIN 00048291
Health Canada record
| Active ingredient(s) | SODIUM ARSANILATE 75.6 MG |
|---|---|
| Dosage form | Solution |
| Route | Oral |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Veterinary |
| ATC | |
| Original market date | 31-Dec-1971 |
| Current status date | 26-Mar-2010 |
| Source | Health Canada DPD |
Establishment licence of the holder
Vetoquinol N A Inc. — licence 100448, currently licensed, last inspection rating C (2025-10-20).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing SODIUM ARSANILATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00159166 | ARSANADEXINE LIQ 2.268GM/30ML | P.V.U., DIVISION OF VÉTOQUINOL N.-A. INC. | Liquid | SODIUM ARSANILATE 2.268 G | Cancelled Post Market |
| 02193906 | ARSENILATE SOLUTION | MEDPRODEX INC. | Liquid | SODIUM ARSANILATE 75.6 MG | Cancelled Post Market |
| 00331821 | COCCI BOL O TAB JR | INTERVET CANADA CORP | Bolus | SODIUM ARSANILATE 0.1814 G; SULFACETAMIDE SODIUM 0.486 G; SULFABENZAMIDE SODIUM 0.486 G; SULFAQUINOXALINE 0.6071 G; FERROUS GLUCONATE 0.243 G; CUPRIC SULFATE 0.972 G; TANNIC ACID 0.570 G; CHARCOAL ACTIVATED 0.729 G; CALCIUM CARBONATE 0.729 G; COBALT GLUCONATE 0.0246 G | Cancelled Post Market |
| 00714984 | COCCI BOL-O-TAB | INTERVET CANADA CORP | Bolus | SODIUM ARSANILATE 486 MG; SULFACETAMIDE SODIUM 1.296 G; SULFABENZAMIDE SODIUM 1.296 G; SULFAQUINOXALINE 1.62 G; FERROUS GLUCONATE 648 MG; CUPRIC SULFATE 2.592 G; TANNIC ACID 1.523 G; CHARCOAL ACTIVATED 1.944 G; CALCIUM CARBONATE 1.944 G; COBALT GLUCONATE 64.8 MG | Cancelled Post Market |
| 00097284 | SODIUM ARSANILATE SOLUTION 35GR | DOMINION VETERINARY LABORATORIES LTD. | Solution | SODIUM ARSANILATE 2.275 G | Dormant |
| 00608041 | SODIUM ARSELINATE SOLUTION | AUSTIN, DIVISION OF VÉTOQUINOL N.-A. INC. | Solution | SODIUM ARSANILATE 2.275 G | Cancelled Post Market |
International API supply for SODIUM ARSANILATE
0 active FDA Drug Master Files.
Request a quote for ARSENILATE SOLUTION